{"id":"W2034014431","doi":"10.2165/11588350-000000000-00000","title":"Adjuvant Trastuzumab for Breast Cancer","year":2011,"lang":"en","type":"article","venue":"PharmacoEconomics","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"Nova Scotia Cancer Centre; Atlantic School of Theology; Cancer Care Nova Scotia; Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Trastuzumab; Breast cancer; Adjuvant; Quality of Life Research; Medicine; Oncology; Health economics; Internal medicine; Public health; Cancer; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001327881,0.0001076296,0.0002542138,0.0003148837,0.0001373443,0.0004212688,0.0001716832,0.0004780181,0.004169399],"category_scores_gemma":[0.006795987,0.00005054677,0.0002884428,0.0005266146,0.0001274703,0.0002858232,0.0002128993,0.000761668,0.000194705],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001556686,"about_ca_system_score_gemma":0.001527145,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001631769,"about_ca_topic_score_gemma":0.004619338,"domain_scores_codex":[0.9990689,0.0005589299,0.00006064479,0.00004327562,0.0001693787,0.00009894239],"domain_scores_gemma":[0.9975597,0.001678384,0.0003325842,0.00007129222,0.0001183288,0.0002396803],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.01443957,0.0007416878,0.02122479,0.000832696,0.0004585367,0.0005684253,0.0000673944,0.003641566,0.002291063,0.005738914,0.02761686,0.9223785],"study_design_scores_gemma":[0.01280487,0.01065457,0.366211,0.004106826,0.004773142,0.005102387,0.0005501484,0.0219703,0.009854874,0.03709656,0.5267997,0.00007583273],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.5330793,0.2163814,0.003501914,0.1599401,0.00195078,0.0002761466,0.002163923,0.0001162425,0.08259017],"genre_scores_gemma":[0.9566142,0.02705575,0.0007860129,0.008429543,0.002164328,0.000082028,0.0005189776,0.00001124403,0.004337854],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004169399,"threshold_uncertainty_score":0.01394802,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1428086307434459,"score_gpt":0.4348955413737136,"score_spread":0.2920869106302676,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}